Abacus Wealth Partners »

Taysha Gene Therapies shares owned by Abacus Wealth Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Abacus Wealth Partners from 13F filings

Historical chart of Abacus Wealth Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Abacus Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Abacus Wealth Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $304k 55k 5.50

More positions owned by Abacus Wealth Partners

Vert Global Sustainable Real Estate ETF Etf (VGSR)
DFA Dimensional Glbl Sustainability Fx Inc ETF Etf (DFSB)
Dimensional U S Targeted Value ETF Etf (DFAT)
Nuveen ESG Small-Cap ETF Etf (NUSC)
Adasina Social Justice All Cap Global ETF Etf (JSTC)
Dimensional US Sustainability Core 1 ETF Etf (DFSU)
Nuveen ESG Mid-Cap Value ETF Etf (NUMV)
Dimensional Intl Sustainability Core 1 ETF Etf (DFSI)
Nuveen ESG Emerging Markets Equity ETF Etf (NUEM)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Dimensional Emg Mkts Sustainability Core 1 ETF Etf (DFSE)
Microsoft Corp Common Stock (MSFT)
Dimensional Intern Small Cap VL ETF Etf (DISV)
Taiwan Semiconductor M F Common Stock (TSM)

View all positions for Abacus Wealth Partners

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies